NCT03330938.

Trial name or title	Decreasing depression and anxiety and their effect on QoL of ESRD patients (end‐stage renal disease) (ESRD)
Methods	Depressed patients with ESKD were randomised to the cognitive‐behavioural intervention and resilience group (intervention group) or cognitive‐behavioural Intervention without resilience
Participants	Inclusion criteria Participants older 18 and younger than 61 years; both genders; depression score in the BDI > 30 points; anxiety score in the BAI > 40 points; have not been hospitalised over the last 6 months; signing of informed consent Exclusion criteria Patients who were not be able to communicate in the Spanish language; presence of psychiatric comorbidity (suicide ideation or depressive or anxious)
Interventions	Treatment group CBT and resilience 8 sessions total, once a week for eight weeks, 2 hours long each, consistent of 6 sessions of CBT plus 2 sessions to improve resilience strengths Control group CBT 8 sessions total, once a week, 2 hours long each. CBT without resilience strengthening
Outcomes	HRQoL KDQOL 36
Starting date	December 2017
Contact information	Cristina Jazmín Gonzalez Flores; Email: crisjaz_10@hotmail.com
Notes	Setting: Hospital Civil de Guadalajara, Jalisco, Mexico. Trial registration number: NCT03330938